Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
Abstract Introduction Sustained remission should be considered the main therapeutic target in psoriatic arthritis (PsA). Very low disease activity (VLDA) and a DAPSA score ≤ 4 are the most commonly used criteria. The aim of the present study was to evaluate the rate of sustained remission in a group...
Main Authors: | Ennio Lubrano, Fabio Massimo Perrotta, Silvia Scriffignano, Laura C. Coates, Philip Helliwell |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2019-08-01
|
Series: | Rheumatology and Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s40744-019-00171-w |
Similar Items
-
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
by: Ennio Lubrano, et al.
Published: (2023-07-01) -
Ultrasonographic Evaluation of Entheseal Fibrocartilage in Patients with Psoriatic Arthritis, Athletes and Healthy Controls: A Comparison Study
by: Fabio Massimo Perrotta, et al.
Published: (2023-04-01) -
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective
by: Ennio Lubrano, et al.
Published: (2022-12-01) -
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study
by: F.M. Perrotta, et al.
Published: (2020-04-01) -
Psoriatic Arthritis in Males and Females: Differences and Similarities
by: Ennio Lubrano, et al.
Published: (2023-02-01)